MedTrace Logo

Comparative Effectiveness of POC-A1c vs the Current Standard Based on OGTT for Early Detection DM2 in Colombia

NCT05440968 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 902

Last updated 2023-08-31

No results posted yet for this study

Summary

Evaluate the impact of conducting a screening questionnaire (FINDRISC) and the implementation of a point-of-care HBA1c test for those with identified risk to suffer Diabetes in ten years, to improve the proportion of patients attending for a confirmatory test ( oral glucose tolerance test ) and evaluate the impact of such a strategy to minimize type 2 diabetes outcomes.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

Point of Care - Glycated Hemoglobin (A1c)

Test for diagnosis of Diabetes through a Point of care device

OTHER

Oral Glucose Tolerance Test

Routinary diagnosis diabetes test by venous blood sample

Sponsors & Collaborators

  • Humberto Reynales MD MSc PhD

    lead NETWORK

Principal Investigators

  • Humberto Reynales, MD MSc PhD · Physician

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-30
Primary Completion
2022-11-02
Completion
2023-09-20

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05440968 on ClinicalTrials.gov